The global demand for Prenatal and Newborn Genetic Testing Market is presumed to reach the market size of nearly USD 15.03 BN by 2030 from USD 5.94 BN in 2022 with a CAGR of 12.3% under the study period 2023 - 2030.
Prenatal and newborn genetic testing are medical procedures performed during pregnancy or shortly after birth to evaluate the genetic health of the fetus or newborn. These tests are used to identify genetic disorders, chromosomal abnormalities, or other inherited conditions that may affect the baby's health.
The increasing prevalence of genetic disorders and chromosomal abnormalities among newborns has created a greater demand for these tests. Parents and healthcare providers recognize the importance of early detection and management of genetic conditions to provide appropriate medical care. Innovations such as non-invasive prenatal testing (NIPT) and next-generation sequencing (NGS) have made genetic testing more accessible, accurate, and less invasive. This has expanded the options for testing and improved detection rates, driving the market growth. The emphasis on personalized medicine has further boosted the prenatal and newborn genetic testing market. Tailoring medical treatments based on an individual's genetic makeup requires thorough genetic profiling, and these tests provide essential information for personalized approaches. The trend of delayed childbearing has contributed to market growth as well. Government initiatives, supportive regulations, and reimbursement policies have also played a vital role. Many governments have implemented programs for newborn screening, making these tests more accessible and affordable for individuals. Increasing awareness, education, and ethical considerations have further fueled the demand for genetic testing. Parents are more proactive in seeking these tests to assess the risk of inherited conditions and make informed decisions about their child's health.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of prenatal and newborn genetic testing. The growth and trends of prenatal and newborn genetic testing industry provide a holistic approach to this study.
This section of the prenatal and newborn genetic testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
By Screening
By Disease
By End User
This section covers the regional outlook, which accentuates current and future demand for the Prenatal and Newborn Genetic Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Prenatal and Newborn Genetic Testing market include PerkinElmer Inc., Quest Diagnostics Incorporated, F. Hoffmann-La Roche AG, Abbott Laboratories, Mettler Toledo, BGI Group, Natera, Inc., Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . PRENATAL AND NEWBORN GENETIC TESTING – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product Type
3.7.2 Market Attractiveness Analysis By Screening
3.7.3 Market Attractiveness Analysis By Disease
3.7.4 Market Attractiveness Analysis By End User
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL PRENATAL AND NEWBORN GENETIC TESTING MARKET ANALYSIS BY PRODUCT TYPE
5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Consumables Historic and Forecast Sales by Regions
5.5 Instruments Historic and Forecast Sales by Regions
6 . GLOBAL PRENATAL AND NEWBORN GENETIC TESTING MARKET ANALYSIS BY SCREENING
6.1 Overview by Screening
6.2 Historical and Forecast Data
6.3 Analysis by Screening
6.4 Non-invasive Prenatal Testing Historic and Forecast Sales by Regions
6.5 Chronic Vi ...